Biostax Corp. and Statera Biopharma, Inc. Reach Mutually Beneficial Dispute Settlement and Amended License Agreement Providing Clearer Clinical and Commercial Pathways for Both Companies

GlobeNewswireApr 20, 2023 09:12 ET

Statera Plans to Merger With Diagnostics Company Worksite

Seeking AlphaMar 15, 2023 09:01 ET

Press Release: Statera Biopharma Signs Letter of Intent for Merger With Worksite Labs

Dow JonesMar 15, 2023 08:02 ET

Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others

Seeking AlphaMar 1, 2023 18:26 ET

Delisting of Securities of EQONEX LIMITED; Scopus BioPharma Inc.; Peak Bio, Inc.; Statera Biopharma, Inc.; Tricida, Inc.; Arbor Rapha Capital Bioholdings Corp. I; Calithera Biosciences, Inc.; Waitr Holdings Inc.; Allied Healthcare Products, Inc.; and Meta

GlobeNewswireMar 1, 2023 16:17 ET

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga Real-time NewsDec 30, 2022 16:34 ET